Soligenix's COVID-19 Vaccine Candidate As Booster Neutralizes Delta, Omicron Variants
Soligenix Inc (NASDAQ:SNGX) announced the results of a booster vaccination study using CiVax (heat-stable COVID-19 subunit vaccine program) in non-human primates (NHPs). The data demonstrated rapid enhancement of neutralizing antibody responses to SARS-CoV-2, including against Delta and Omicron variants. The NHPs had been double vaccinated with an adenovirus vaccine for COVID-19 seven months…
Benzinga ·
Benzinga
